<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-IVF-2876</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-2876</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Функциональная активность Т-лимфоцитов в условиях “клеточного соседства” пролиферирующих и апоптотирующих клеток in vitro у здоровых людей и пациентов с ревматоидным артритом</article-title><trans-title-group xml:lang="en"><trans-title>In vitro functional activity of T lymphocytes under the conditions of ‘cell neighborhood’ of proliferating and apoptotic cells in healthy people and patients with rheumatoid arthritis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6947-2212</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Абрамова</surname><given-names>Т. Я.</given-names></name><name name-style="western" xml:lang="en"><surname>Abramova</surname><given-names>T. Ya.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Абрамова Т.Я. – д.м.н., ведущий научный сотрудник лаборатории клинической иммунопатологии </p><p>г. Новосибирск</p></bio><bio xml:lang="en"><p>Abramova T. Ya., PhD, MD (Medicine), Leading Research Associate, Laboratory of Clinical Immunopathology </p><p>Novosibirsk</p></bio><email xlink:type="simple">tatjana-abramova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3327-3630</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Блинова</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Blinova</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Блинова Е.А. – к.б.н., старший научный сотрудник лаборатории клинической иммунопатологии </p><p>г. Новосибирск</p></bio><bio xml:lang="en"><p>Blinova E.A., PhD (Biology), Senior Research Associate, Laboratory of Clinical Immunopathology </p><p>Novosibirsk</p></bio><email xlink:type="simple">blinovaelena-85@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4912-5512</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пашкина</surname><given-names>Е. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Pashkina</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Пашкина Е.А. – к.б.н., старший научный сотрудник лаборатории клинической иммунопатологии </p><p>г. Новосибирск</p></bio><bio xml:lang="en"><p>Pashkina E.A., PhD (Biology), Senior Research Associate, Laboratory of Clinical Immunopathology </p><p>Novosibirsk</p></bio><email xlink:type="simple">pashkina.e.a@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3868-938X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гришина</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Grishina</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Гришина Л.В. – к.б.н., научный сотрудник лаборатории клинической иммунопатологии </p><p>г. Новосибирск</p></bio><bio xml:lang="en"><p>Grishina L.V., PhD (Biology), Research Associate, Laboratory of Clinical Immunopathology </p><p>Novosibirsk</p></bio><email xlink:type="simple">l_grishina@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8633-0662</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ильина</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ilina</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ильина Н.А. – врач-ревматолог клиники иммунопатологии </p><p>г. Новосибирск</p></bio><bio xml:lang="en"><p>Ilina N.A., Rheumatologist, Clinic of Immunopathology </p><p>Novosibirsk</p></bio><email xlink:type="simple">nadya5481@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3797-6392</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чумасова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Chumasova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чумасова О.А. – к.м.н., врач-ревматолог клиники иммунопатологии </p><p>г. Новосибирск</p></bio><bio xml:lang="en"><p>Chumasova O.A., PhD (Medicine), Rheumatologist, Clinic of Immunopathology </p><p>Novosibirsk</p></bio><email xlink:type="simple">chumoks@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7213-7482</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сизиков</surname><given-names>А. Э.</given-names></name><name name-style="western" xml:lang="en"><surname>Sizikov</surname><given-names>A. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сизиков А.Э. – к.м.н., заведующий отделением ревматологии – врач-ревматолог клиники иммунопатологии </p><p>г. Новосибирск</p></bio><bio xml:lang="en"><p>Sizikov A.E., PhD (Medicine), Head, Rheumatology Department, Clinic of Immunopathology </p><p>Novosibirsk</p></bio><email xlink:type="simple">depaidici@online.nsk.su</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1756-1782</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Козлов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kozlov</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Козлов В.А. – д.м.н., академик РАН, заведующий лабораторией клинической иммунопатологии, научный консультант </p><p>г. Новосибирск</p></bio><bio xml:lang="en"><p>Kozlov V.A., PhD, MD (Medicine), Professor, Full Member, Russian Academy of Sciences, Head, Laboratory of Clinical Immunopathology, Scientific Advisor </p><p>Novosibirsk</p></bio><email xlink:type="simple">vakoz40@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт фундаментальной и клинической иммунологии»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute of Fundamental and Clinical Immunology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>17</day><month>10</month><year>2023</year></pub-date><volume>26</volume><issue>6</issue><fpage>1279</fpage><lpage>1290</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Абрамова Т.Я., Блинова Е.А., Пашкина Е.А., Гришина Л.В., Ильина Н.А., Чумасова О.А., Сизиков А.Э., Козлов В.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Абрамова Т.Я., Блинова Е.А., Пашкина Е.А., Гришина Л.В., Ильина Н.А., Чумасова О.А., Сизиков А.Э., Козлов В.А.</copyright-holder><copyright-holder xml:lang="en">Abramova T.Y., Blinova E.A., Pashkina E.A., Grishina L.V., Ilina N.A., Chumasova O.A., Sizikov A.E., Kozlov V.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/2876">https://www.mimmun.ru/mimmun/article/view/2876</self-uri><abstract><p>Ревматоидный артрит (РА) представляет собой хроническое, системное, воспалительное, аутоиммунное заболевание, развитие которого ассоциировано с нарушением механизмов контроля численности клеток, баланса процессов пролиферации и апоптоза. Целью исследования являлся комплексный анализ влияния клеточных и гуморальных факторов «апоптотирующей» культуры Т-лимфоцитов на «пролиферирующую» с учетом данных по параметрам «первичной» и «вторичной» индукции апоптоза, активационных маркеров и маркера пролиферации, содержания живых клеток, роли кортизола, каспазы и цитокинов при культивировании в условиях «клеточного соседства» у здоровых людей и пациентов с РА. Результаты анализа, проведенного с учетом полученных ранее данных, выявили сходные и различающиеся функции созданных в условиях «клеточного соседства» Т-клеточных систем здоровых людей и пациентов с РА. Для обеих исследуемых групп была характерна вторичная индукция апоптоза, относящаяся к неавтономным эффектам, появление значимого количества активированных Т-лимфоцитов, повышение уровней IL-6 и IL-4, низкий уровень IFNγ и каспазы-8, снижение потенциала рецепторного и митохондриального апоптоза, а также отсутствие различий по уровню апоптоза между группами доноров и пациентов. В то же время у здоровых людей в процессе индукции апоптоза снижался высокий изначально уровень TNFα, а повышение IL-6 было умеренным. Не изменялись уровни внутриклеточных молекул р53 и Bcl-2, сохранялось большое количество положительных корреляционных зависимостей между исследуемыми факторами во всех вариантах смешанных и «апоптотических» культур, что свидетельствовало о сохранении функционального баланса Т-клеток в неблагоприятных условиях у доноров. Пациентов с РА характеризовало повышение числа живых клеток в «апоптотических» культурах, значимый рост количества Ki-67+ Т-лимфоцитов, свидетельствующее о пролиферативных процессах в условиях апоптоза, отсутствие ответа TNFα на индукцию апоптоза, отсутствие связей между исследуемыми молекулами в «апоптотических» культурах и синтез кортизола в них, а также наличие связей кортизола с исследуемыми молекулами в апоптотических культурах, что свидетельствовало об изменении межклеточных взаимодействий и нарушении гомеостаза Т-лимфоцитов в условиях «клеточного соседства» у пациентов с РА.</p></abstract><trans-abstract xml:lang="en"><p>Rheumatoid arthritis (RA) is a chronic, systemic, inflammatory, autoimmune disease, the development of which is associated with impaired mechanisms of cell number control, proliferation balance, and apoptosis. The aim of our study was to perform a comprehensive analysis of cellular and humoral effects exerted by “apoptotic” T lymphocyte culture upon “proliferating” cells, taking into account the parameters of “primary” and “secondary” apoptosis induction, activation and proliferation markers, viable cell contents, role of cortisol, caspase and cytokines during cultivation under the “cell neighborhood” conditions in healthy subjects and patients with RA. The results of the analysis, with respect to previous data, revealed both similar and different functions of the T cell systems generated under “cell-neighborhood” conditions in healthy individuals and RA patients. Both groups under study were characterized by secondary induction of apoptosis, which refers to non-autonomous effects, along with appearance of activated T lymphocytes at significant amounts, increase of IL-6 and IL-4 levels, as well as low levels of IFNγ and caspase 8, decrease potential of receptor and mitochondrial apoptosis. No differences in apoptosis level were found between donor and patient groups. At the same time, the initially high level of TNFα in healthy subjects decreased during the induction of apoptosis, along with moderate increase of IL-6. The levels of intracellular p53 and Bcl-2 molecules did not change, and many positive correlations remained between the studied factors in all variants of mixed and “apoptotic” cultures, thus suggesting maintenance of functional T cell balance under the unfavorable conditions in donors. The RA patients were characterized by increased number of live cells in “apoptotic” cultures, a significant increase in the number of Ki-67+ T lymphocytes, being indicative for proliferative processes under conditions of apoptosis, like as absence of TNFα response to apoptosis induction. Lack of relations between the studied molecules in “apoptotic” cultures and local cortisol synthesis, as well as presence of correlations between cortisol and the studied molecules in apoptotic cultures, presumed some changes of intercellular interactions and disturbance of homeostasis among T lymphocytes under the conditions of “cellular neighborhood” were also observed in RA patients.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Т-лимфоциты</kwd><kwd>«пролиферирующие» клетки</kwd><kwd>«апоптотирующие» клетки</kwd><kwd>автономные эффекты апоптоза</kwd><kwd>не автономные эффекты апоптоза</kwd><kwd>«клеточное соседство»</kwd><kwd>локальная продукция кортизола</kwd><kwd>ревматоидный артрит</kwd></kwd-group><kwd-group xml:lang="en"><kwd>T cells</kwd><kwd>apoptosis</kwd><kwd>autonomous effects</kwd><kwd>non-autonomous effects</kwd><kwd>cell neighborhood</kwd><kwd>cortisol</kwd><kwd>local production</kwd><kwd>rheumatoid arthritis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Абрамова Т.Я., Блинова Е.А., Гришина Л.В., Чумасова О.А., Сулутьян А.Э., Сизиков А.Э., Козлов В.А. Исследование неавтономных эффектов апоптоза в процессе инициации апоптотической гибели клеток in vitro у здоровых людей и пациентов с ревматоидным артритом // Медицинская иммунология, 2020. Т. 22, № 5. С. 847-866. doi: 10.15789/1563-0625-SON-1991.</mixed-citation><mixed-citation xml:lang="en">Abramova T.Ya., Blinova E.A., Grishina L.V., Chumasova O.A., Sulut’yan A.E., Sizikov A.E., Kozlov V.A. Studies of non-autonomous effects of apoptosis in the course of in vitro apoptotic cell death initiation in healthy persons and patients with rheumatoid arthritis. Meditsinskaya immunologiya = Medical Immunology (Russia), 2020, Vol. 22, no. 5, pp. 847-866. (In Russ.) doi: 10.15789/1563-0625-SON-1991.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Абрамова Т.Я., Блинова Е.А., Пашкина Е.А., Гришина Л.В., Ильина Н.А., Чумасова О.А., Сизиков А.Э., Козлов В.А. Исследование эффекторных молекул автономного и неавтономного влияния апоптоза Т-лимфоцитов в условиях «клеточного соседства» в культуре у здоровых людей и пациентов с РА // Медицинская иммунология, 2022. Т. 24, № 6. С. 1119-1138. doi: 10.15789/1563-0625-SOE-2527.</mixed-citation><mixed-citation xml:lang="en">Abramova T.Ya., Blinova E.A., Pashkina E.A., Grishina L.V., Ilina N.A., Chumasova O.A., Sizikov A.E., Kozlov V.A. Studies of effector molecules exerting autonomous and nonautonomous influence of T lymphocyte apoptosis under the conditions of in vitro “cell neighborhood” in healthy people and patients with rheumatoid arthritis. Meditsinskaya immunologiya = Medical Immunology (Russia), 2022, Vol. 24, no. 6, pp. 1119-1138. (In Russ.) doi: 10.15789/1563-0625-SOE-2527.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Абрамова Т.Я., Цура В.А., Блинова Е.А., Моренкова А.Ю., Чумасова О.А., Сулутьян А.Э., Сизиков А.Э., Козлов В.А. Индукция апоптоза лимфоцитов здоровых людей и пациентов с ревматоидным артритом в условиях «клеточного соседства» in vitro // Бюллетень сибирской медицины, 2019. Т. 18, № 1. С. 155-163.</mixed-citation><mixed-citation xml:lang="en">Abramova T.Ya., Tsura V.A., Blinova E.A., Morenkova A.Yu., Chumasova O.A., Sulutian A.E., Sizikov A.E., Kozlov V.A.. Induction of lymphocyte apoptosis in healthy individuals and patients with rheumatoid arthritis under “cellular neighborhood” in vitro. Byulleten sibirskoy meditsiny = Bulletin of Siberian Medicine, 2019, Vol. 18, no. 1, pp. 155-163. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Cui Y., Guo G. Immunomodulatory Function of the Tumor Suppressor p53 in Host Immune Response and the Tumor Microenvironment. Int. J. Mol. Sci., 2016, Vol. 17, no. 11, 1942. doi: 10.3390/ijms17111942.</mixed-citation><mixed-citation xml:lang="en">Cui Y., Guo G. Immunomodulatory Function of the Tumor Suppressor p53 in Host Immune Response and the Tumor Microenvironment. Int. J. Mol. Sci., 2016, Vol. 17, no. 11, 1942. doi: 10.3390/ijms17111942.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Iwaszko M., Biały S., Bogunia-Kubik K. Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis. Cells, 2021, Vol. 10, no. 11, 3000. doi: 10.3390/cells10113000.</mixed-citation><mixed-citation xml:lang="en">Iwaszko M., Biały S., Bogunia-Kubik K. Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis. Cells, 2021, Vol. 10, no. 11, 3000. doi: 10.3390/cells10113000.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kalliolias, G.D., Ivashkiv L.B. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat. Rev. Rheumatol., 2016, Vol .12, no. 1, pp. 49-62.</mixed-citation><mixed-citation xml:lang="en">Kalliolias, G.D., Ivashkiv L.B. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat. Rev. Rheumatol., 2016, Vol .12, no. 1, pp. 49-62.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kato M. New insights into IFN-γ in rheumatoid arthritis: role in the era of JAK inhibitors. Immunol. Med., 2020, Vol. 43, no. 2, pp. 72-78.</mixed-citation><mixed-citation xml:lang="en">Kato M. New insights into IFN-γ in rheumatoid arthritis: role in the era of JAK inhibitors. Immunol. Med., 2020, Vol. 43, no. 2, pp. 72-78.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kawamoto Y., Nakajima Y.I., Kuranaga E. Apoptosis in cellular society: communication between apoptotic cells and their neighbors. Int. J. Mol. Sci., 2016, Vol. 17, no. 12, 2144. doi: 10.3390/ijms17122144.</mixed-citation><mixed-citation xml:lang="en">Kawamoto Y., Nakajima Y.I., Kuranaga E. Apoptosis in cellular society: communication between apoptotic cells and their neighbors. Int. J. Mol. Sci., 2016, Vol. 17, no. 12, 2144. doi: 10.3390/ijms17122144.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kondo N., Kuroda T., Kobayashi D. Cytokine networks in the pathogenesis of rheumatoid arthritis. Int. J. Mol. Sci., 2021, Vol. 22, no. 20, 10922. doi: 10.3390/ijms222010922.</mixed-citation><mixed-citation xml:lang="en">Kondo N., Kuroda T., Kobayashi D. Cytokine networks in the pathogenesis of rheumatoid arthritis. Int. J. Mol. Sci., 2021, Vol. 22, no. 20, 10922. doi: 10.3390/ijms222010922.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Luo P., Wang P., Xu J., Hou W., Xu P., Xu K., Liu L. Immunomodulatory role of T helper cells in rheumatoid arthritis : a comprehensive research review. Bone Joint Res., 2022, Vol. 11, no. 7, pp. 426-438.</mixed-citation><mixed-citation xml:lang="en">Luo P., Wang P., Xu J., Hou W., Xu P., Xu K., Liu L. Immunomodulatory role of T helper cells in rheumatoid arthritis : a comprehensive research review. Bone Joint Res., 2022, Vol. 11, no. 7, pp. 426-438.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Pandolfi F., Franza L., Carusi V., Altamura S., Andriollo G., Nucera E. Interleukin-6 in rheumatoid arthritis. Int. J. Mol. Sci., 2020, Vol. 21, no. 15, 5238. doi: 10.3390/ijms21155238.</mixed-citation><mixed-citation xml:lang="en">Pandolfi F., Franza L., Carusi V., Altamura S., Andriollo G., Nucera E. Interleukin-6 in rheumatoid arthritis. Int. J. Mol. Sci., 2020, Vol. 21, no. 15, 5238. doi: 10.3390/ijms21155238.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Pérez-Garijo A. When dying is not the end: Apoptotic caspases as drivers of proliferation. Semin. Cell Dev. Biol., 2018, Vol. 82, pp. 86-95.</mixed-citation><mixed-citation xml:lang="en">Pérez-Garijo A. When dying is not the end: Apoptotic caspases as drivers of proliferation. Semin. Cell Dev. Biol., 2018, Vol. 82, pp. 86-95.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Shimba A., Ikuta K. Control of immunity by glucocorticoids in health and disease. Semin. Immunopathol., 2020, Vol. 42, no. 6, pp. 669-680.</mixed-citation><mixed-citation xml:lang="en">Shimba A., Ikuta K. Control of immunity by glucocorticoids in health and disease. Semin. Immunopathol., 2020, Vol. 42, no. 6, pp. 669-680.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Slominski R.M., Tuckey R.C., Manna P.R., Jetten A.M., Postlethwaite A., Raman C., Slominski A.T. Extraadrenal glucocorticoid biosynthesis: implications for autoimmune and inflammatory disorders. Genes Immun., 2020, Vol. 21, no. 3, pp. 150-168.</mixed-citation><mixed-citation xml:lang="en">Slominski R.M., Tuckey R.C., Manna P.R., Jetten A.M., Postlethwaite A., Raman C., Slominski A.T. Extraadrenal glucocorticoid biosynthesis: implications for autoimmune and inflammatory disorders. Genes Immun., 2020, Vol. 21, no. 3, pp. 150-168.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Taves M.D., Ashwell J.D. Glucocorticoids in T cell development, differentiation and function. Nat. Rev. Immunol., 2021, Vol. 21, no. 4, pp. 233-243.</mixed-citation><mixed-citation xml:lang="en">Taves M.D., Ashwell J.D. Glucocorticoids in T cell development, differentiation and function. Nat. Rev. Immunol., 2021, Vol. 21, no. 4, pp. 233-243.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
